LEADGENE BIOMEDICAL INC

Yongkang, Tainan City, Taiwan leadgenebio.com

Overview

LEADGENE BIOMEDICAL INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering RECOMBINANT PROTEIN (LGX-23001; LDG002/003PHE-GMP; LDG009PHE-GMP; LDG013/014PHE-GMP).

API / Drug Master Files

LEADGENE BIOMEDICAL INC holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • RECOMBINANT PROTEIN (LGX-23001; LDG002/003PHE-GMP; LDG009PHE-GMP; LDG013/014PHE-GMP)Active2024-10-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LEADGENE BIOMEDICAL INC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

3dl Cosmetics Lab Inc.
Taiwan
Able Advanced Chemicals. Co., Ltd. ( Aacc )
Taiwan
Adimmune Corp (4142)
Taiwan
Aftek 台灣艾富克
Taiwan
Alljack Technologies, Inc.
Taiwan
Anxo Pharmaceutical Taiwan Co. Ltd
Taiwan
Apex Health Care Mfg., Inc （榕懋實業股份有限公司）
Taiwan
Apexlens Co., Ltd.
Taiwan

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo